The cause of idiopathic P arkinson's disease (IP D ) is unknow n, but reduced activity of com plex I of the electron-transport chain has been im plicated in the pathogenesis of IP D . H yperhom ocysteinem ia is a w ellestablished risk factor for cardiovascular and cerebrovascular diseases. H ow ever, recent evidence suggests that changes in the m etabolic fate of hom ocysteine, leading to hyperhom ocysteinem ia, m ay also play a role in the pathophysiology of IP D . M ethods: A ge and sex-m atched 4 1 drug-naive IPD patients (1 6 m en and 2 5 w om en) and 1 6 1 healthy controls (6 6 m en and 9 5 w om en) w ere included in this study. Their fasting plasm a hom ocystein and folate level, and the genotypes of m ethylenetetrahydrofolate reductase (M TH FR ) w ere analyzed. R esu lts: The plasm a level of hom ocysteine w as higher in untreated IPD patients (1 2 .0 ±2 .9 μm ol/ L) com pared to the controls (9 .0 ±2 .6 μ m ol/ L) (p =0 .0 0 1 ). The frequencies of M TH FR C6 7 7 T genotypes w ere not different betw een patients (CC :CT:TT=7 :2 3 :1 1 ) and controls (C C:C T:TT=2 7 :8 6 :4 8 ) (p =0 .9 3 0 ). The adjusted odds ratio of hom ocysteine w as rem arkable (adjusted OR =1 .1 4 9 , 9 5 % confidential interval=1 .6 6 -2 .2 8 , p=0 .0 0 4 ). C onclusions: IP D patients have higher plasma homocysteine level than healthy controls but MTHFR C667T genotype was not related to the homocysteine level. It can be suggested that increased plasm a hom ocysteine level m ay contribute to the pathogenesis of IPD . 

